Literature DB >> 19217670

Sex differences in the behavior of children with the 22q11 deletion syndrome.

Christina Sobin1, Karen Kiley-Brabeck, Samantha Hadley Monk, Jananne Khuri, Maria Karayiorgou.   

Abstract

High rates of psychiatric impairment in adults with 22q11 deletion syndrome (22q11DS, also referred to as DiGeorge or velocardiofacial syndrome) suggest that behavioral trajectories of children with 22q11DS may provide critical etiologic insights. Past findings that report Diagnostic and Statistical Manual (DSM) diagnoses are extremely variable; moreover, sex differences in behavior have not yet been examined. Child Behavior Checklist (CBCL) ratings from 82 children, including 51 with the 22q11DS and 31 control siblings, were analyzed. Strikingly consistent with rates of psychiatric impairment among affected adults, 25% of children with 22q11DS had high CBCL scores for Total Impairment, and 20% had high CBCL Internalizing Scale scores. Males accounted for 90% of high Internalizing scores and 67% of high Total Impairment scores. Attention and Social Problems were ubiquitous; more affected males than females (23% vs. 4%) scored high on Thought Problems. With regard to CBCL/DSM overlap, 20% of affected males as compared with 0 affected females had one or more high CBCL ratings in the absence of a DSM diagnosis. Behaviors of children with 22q11DS are characterized by marked sex differences when rated dimensionally, with significantly more males experiencing Internalizing and Thought Problems. Categorical diagnoses do not reflect behavioral differences between male and female children with 22q11DS, and may miss significant behavior problems in 20% of affected males.

Entities:  

Mesh:

Year:  2009        PMID: 19217670      PMCID: PMC2728438          DOI: 10.1016/j.psychres.2008.03.023

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  14 in total

1.  NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses.

Authors:  D Shaffer; P Fisher; C P Lucas; M K Dulcan; M E Schwab-Stone
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-01       Impact factor: 8.829

2.  Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives.

Authors:  A E Pulver; G Nestadt; R Goldberg; R J Shprintzen; M Lamacz; P S Wolyniec; B Morrow; M Karayiorgou; S E Antonarakis; D Housman
Journal:  J Nerv Ment Dis       Date:  1994-08       Impact factor: 2.254

3.  The velo-cardio-facial syndrome: a clinical and genetic analysis.

Authors:  R J Shprintzen; R B Goldberg; D Young; L Wolford
Journal:  Pediatrics       Date:  1981-02       Impact factor: 7.124

4.  Velo-cardio-facial syndrome: Implications of microdeletion 22q11 for schizophrenia and mood disorders.

Authors:  P D Arnold; J Siegel-Bartelt; C Cytrynbaum; I Teshima; R Schachar
Journal:  Am J Med Genet       Date:  2001-05-08

5.  Psychiatric disorders and behavioral problems in children with velocardiofacial syndrome: usefulness as phenotypic indicators of schizophrenia risk.

Authors:  Carl Feinstein; Stephan Eliez; Christine Blasey; Allan L Reiss
Journal:  Biol Psychiatry       Date:  2002-02-15       Impact factor: 13.382

6.  Children with a 22q11 deletion versus children with a speech-language impairment and learning disability: behavior during primary school age.

Authors:  A Swillen; K Devriendt; P Ghesquière; J P Fryns
Journal:  Genet Couns       Date:  2001

7.  Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children.

Authors:  Tanya E Froehlich; Bruce P Lanphear; Jeffery N Epstein; William J Barbaresi; Slavica K Katusic; Robert S Kahn
Journal:  Arch Pediatr Adolesc Med       Date:  2007-09

8.  A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population.

Authors:  Lorenzo D Botto; Kristin May; Paul M Fernhoff; Adolfo Correa; Karlene Coleman; Sonja A Rasmussen; Robert K Merritt; Leslie A O'Leary; Lee-Yang Wong; E Marsha Elixson; William T Mahle; Robert M Campbell
Journal:  Pediatrics       Date:  2003-07       Impact factor: 7.124

9.  Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11.

Authors:  M Karayiorgou; M A Morris; B Morrow; R J Shprintzen; R Goldberg; J Borrow; A Gos; G Nestadt; P S Wolyniec; V K Lasseter
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

10.  Neuropsychiatric disorders in the 22q11 deletion syndrome.

Authors:  L Niklasson; P Rasmussen; S Oskarsdóttir; C Gillberg
Journal:  Genet Med       Date:  2001 Jan-Feb       Impact factor: 8.822

View more
  8 in total

1.  Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice.

Authors:  Michael Didriksen; Kim Fejgin; Simon R O Nilsson; Michelle R Birknow; Hannah M Grayton; Peter H Larsen; Jes B Lauridsen; Vibeke Nielsen; Pau Celada; Noemi Santana; Pekka Kallunki; Kenneth V Christensen; Thomas M Werge; Tine B Stensbøl; Jan Egebjerg; Francois Gastambide; Francesc Artigas; Jesper F Bastlund; Jacob Nielsen
Journal:  J Psychiatry Neurosci       Date:  2017-01       Impact factor: 6.186

2.  A French multicenter study of over 700 patients with 22q11 deletions diagnosed using FISH or aCGH.

Authors:  Céline Poirsier; Justine Besseau-Ayasse; Caroline Schluth-Bolard; Jérôme Toutain; Chantal Missirian; Cédric Le Caignec; Anne Bazin; Marie Christine de Blois; Paul Kuentz; Marie Catty; Agnès Choiset; Ghislaine Plessis; Audrey Basinko; Pascaline Letard; Elisabeth Flori; Mélanie Jimenez; Mylène Valduga; Emilie Landais; Hakima Lallaoui; François Cartault; James Lespinasse; Dominique Martin-Coignard; Patrick Callier; Céline Pebrel-Richard; Marie-France Portnoi; Tiffany Busa; Aline Receveur; Florence Amblard; Catherine Yardin; Radu Harbuz; Fabienne Prieur; Nathalie Le Meur; Eva Pipiras; Pascale Kleinfinger; François Vialard; Martine Doco-Fenzy
Journal:  Eur J Hum Genet       Date:  2015-10-28       Impact factor: 4.246

3.  Discrepancies in parent and teacher ratings of social-behavioral functioning of children with chromosome 22q11.2 deletion syndrome: implications for assessment.

Authors:  Emily Wray; Vandana Shashi; Kelly Schoch; Kathleen Curtiss; Stephen R Hooper
Journal:  Am J Intellect Dev Disabil       Date:  2013-09

4.  Thought problems from adolescence to adulthood: measurement invariance and longitudinal heritability.

Authors:  Abdel Abdellaoui; Marleen H M de Moor; Lot M Geels; Jenny H D A van Beek; Gonneke Willemsen; Dorret I Boomsma
Journal:  Behav Genet       Date:  2011-06-18       Impact factor: 2.805

5.  Neuropsychiatric phenotypes and a distinct constellation of ASD features in 3q29 deletion syndrome: results from the 3q29 registry.

Authors:  Rebecca M Pollak; Melissa M Murphy; Michael P Epstein; Michael E Zwick; Cheryl Klaiman; Celine A Saulnier; Jennifer G Mulle
Journal:  Mol Autism       Date:  2019-07-16       Impact factor: 7.509

Review 6.  Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.

Authors:  Maude Schneider; Martin Debbané; Anne S Bassett; Eva W C Chow; Wai Lun Alan Fung; Marianne van den Bree; Michael Owen; Kieran C Murphy; Maria Niarchou; Wendy R Kates; Kevin M Antshel; Wanda Fremont; Donna M McDonald-McGinn; Raquel E Gur; Elaine H Zackai; Jacob Vorstman; Sasja N Duijff; Petra W J Klaassen; Ann Swillen; Doron Gothelf; Tamar Green; Abraham Weizman; Therese Van Amelsvoort; Laurens Evers; Erik Boot; Vandana Shashi; Stephen R Hooper; Carrie E Bearden; Maria Jalbrzikowski; Marco Armando; Stefano Vicari; Declan G Murphy; Opal Ousley; Linda E Campbell; Tony J Simon; Stephan Eliez
Journal:  Am J Psychiatry       Date:  2014-06       Impact factor: 18.112

7.  Common and specific impairments in attention functioning in girls with chromosome 22q11.2 deletion, fragile X or Turner syndromes.

Authors:  Andrea I Quintero; Elliott A Beaton; Danielle J Harvey; Judith L Ross; Tony J Simon
Journal:  J Neurodev Disord       Date:  2014-03-14       Impact factor: 4.025

8.  Persistent Feeding and Swallowing Deficits in a Mouse Model of 22q11.2 Deletion Syndrome.

Authors:  Lauren Welby; Hailey Caudill; Gelila Yitsege; Ali Hamad; Filiz Bunyak; Irene E Zohn; Thomas Maynard; Anthony-Samuel LaMantia; David Mendelowitz; Teresa E Lever
Journal:  Front Neurol       Date:  2020-01-31       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.